|
|
Langues
|
|
|
Par thème
|
|
|
Par secteur d'activité
|
|
|
Par pays
|
|
|
Page :
1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 ...
|
|
|
|
|
TORONTO, ON / ACCESSWIRE / May 10, 2024 / Edesa Biotech, Inc. Nasdaq:EDSA, a clinicalstage biopharmaceutical company focused on developing hostdirected therapeutics for immunoinflammatory diseases, today reported financial results for the three and six months ended March 31, 2024 and provided an update on its business.During the quarter, the company expanded site selection activities for a Phase... Lire le communiqué |
|
| |
|
| |
|
|
TORONTO, ON / ACCESSWIRE / April 11, 2024 / Edesa Biotech, Inc. NASDAQ:EDSA, a clinicalstage biopharmaceutical company focused on developing hostdirected therapeutics for immunoinflammatory diseases, announced today that the company will participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference scheduled for April 1617, 2024 in Toronto, Ontario.Edesas Chief Executive Officer... Lire le communiqué |
|
| |
|
| |
|
|
TORONTO, ON / ACCESSWIRE / April 2, 2024 / Edesa Biotech, Inc. NASDAQ:EDSA, a clinicalstage biopharmaceutical company focused on developing hostdirected therapeutics for immunoinflammatory diseases, announced today that Edesa management plans to participate in the following upcoming investor conferences:Mintz Conference, Toronto, Canada, April 15, 2024LSX World Congress, London, UK, April 2930,... Lire le communiqué |
|
| |
|
| |
|
|
TORONTO, ON / ACCESSWIRE / March 21, 2024 / Edesa Biotech, Inc. Nasdaq:EDSA, a clinicalstage biopharmaceutical company focused on developing hostdirected therapeutics for immunoinflammatory diseases, announced today that the company will participate in a Fireside Chat and host oneonone meetings at the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference on March 28, 2024.The... Lire le communiqué |
|
| |
|
| |
|
|
TORONTO, ON / ACCESSWIRE / March 7, 2024 / Edesa Biotech, Inc. NASDAQ:EDSA, a clinicalstage biopharmaceutical company focused on developing hostdirected therapeutics for immunoinflammatory diseases, announced today that company management will participate in the Barclays 26th Annual Global Healthcare Conference, which is being held in Miami, Florida, from March 1214, 2024.Attendees interested in... Lire le communiqué |
|
| |
|
| |
|
|
TORONTO, ON / ACCESSWIRE / March 4, 2024 / Edesa Biotech, Inc. NASDAQ:EDSA, a clinicalstage biopharmaceutical company focused on developing hostdirected therapeutics for immunoinflammatory diseases, announced today that the company plans to participate in the American Contact Dermatitis Society Annual Meeting on March 7, 2024 and the American Academy of Dermatology Annual Meeting from March 812,... Lire le communiqué |
|
| |
|
| |
|
|
TORONTO, ON / ACCESSWIRE / February 9, 2024 / Edesa Biotech, Inc. Nasdaq:EDSA, a clinicalstage biopharmaceutical company focused on developing hostdirected therapeutics for immunoinflammatory diseases, today reported financial results for the three months ended December 31, 2023 and provided an update on its business.During the first fiscal quarter, the company secured funding of up to C$23... Lire le communiqué |
|
| |
|
| |
Page :
1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 ...
|
|
|
